↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

127 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   10-mg dose of e5501 2g tablet   -   -   -   -   1件:
63 
 2   10-mg dose of e5501 cyclodextrin oral solution   -   -   -   -   1件:
63 
 3   10-mg dose of e5501 lipid-based oral   -   -   -   -   1件:
63 
 4   10-mg dose of e5501-p21% powder   -   -   -   -   1件:
63 
 5   Akr-501 tablets   -   -   -   -   1件:
63 
 6   Akr-501, ym-477   -   -   -   -   1件:
63 
 7   Alemtuzumab   Alemtuzumab   D02802   -   -   13件:
13,
15,
19,
20,
46,
51,
60,
63,
65,
85,
96,
164,
284 
 8   Alemtuzumab, rituximab   Alemtuzumab   D02802   -   -   1件:
63 
 9   All-trans retinoid acid(atra)   Tretinoin   D00094   3件: PML, RARA, RARB   12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis   1件:
63 
 10   Amg 531   -   -   -   -   1件:
63 
 11   Aminophylline   Aminophylline   D00227, D05429   18件: ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B   23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
63 
 12   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 13   Amoxicillin hydrate   Amoxicillin   D00229, D02925, D07452   -   -   1件:
63 
 14   Amoxycillin   Amoxicillin   D00229, D02925, D07452   -   -   1件:
63 
 15   Anti-d   -   -   -   -   1件:
63 
 16   Argx-113   -   -   -   -   3件:
11,
35,
63 
 17   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 18   Atorvastatin 10mg   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
63 
 19   Atorvastatin 20mg   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
63 
 20   Atra   Tretinoin   D00094   3件: PML, RARA, RARB   12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis   2件:
63,
94 
 21   Avatrombopag   Avatrombopag   D10306   -   -   1件:
63 
 22   Avatrombopag (proposed)   Avatrombopag   D10306   -   -   1件:
63 
 23   Blinded (avatrombopoag tablets)   -   -   -   -   1件:
63 
 24   Blisibimod   Blisibimod   D10311   -   -   5件:
43,
44,
49,
63,
66 
 25   Bms-986004 1500 mg iv   -   -   -   -   1件:
63 
 26   Bms-986004 225 mg iv   -   -   -   -   1件:
63 
 27   Bms-986004 675 mg iv   -   -   -   -   1件:
63 
 28   Bms-986004 75 mg iv   -   -   -   -   1件:
63 
 29   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 30   Bt595   -   -   -   -   2件:
63,
65 
 31   Caffeic acid tablets   -   -   -   -   1件:
63 
 32   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 33   Conventional   -   -   -   -   1件:
63 
 34   Corticosteroids (aprednislon)   -   -   -   -   1件:
63 
 35   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 36   Cyclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   11件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
113,
164 
 37   Decitabine   Decitabine   D03665   3件: DNMT1, DNMT3A, DNMT3B   3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer   1件:
63 
 38   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 39   Dexamethasone (1 cycle)   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
63 
 40   Dexamethasone (4 cycles)   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
63 
 41   Dexamethasone abcur   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
63 
 42   Dexamethasone and rituximab   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
63 
 43   Doxil   Doxorubicin   D03899   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
63 
 44   E5501   -   -   -   -   1件:
63 
 45   E5501 - avatrombopag maleate   Avatrombopag   D10306   -   -   1件:
63 
 46   E5501 40 mg 2 x 20-mg tablets, orally, fasted   -   -   -   -   1件:
63 
 47   E5501 40 mg 2 x 20-mg tablets, orally, with food   -   -   -   -   1件:
63 
 48   E5501 40mg 2 x 20-mg tablets, orally, fasted   -   -   -   -   1件:
63 
 49   Eltrombopag   Eltrombopag   D03978   -   -   3件:
60,
63,
285 
 50   Eltrombopag olamine (sb-497115-gr)   Eltrombopag   D03978   -   -   1件:
63 
 51   Eltrombopag oral tablets   Eltrombopag   D03978   -   -   1件:
63 
 52   Gammaplex, intravenous immunoglobulin   Immune globulin human   -   -   -   1件:
63 
 53   Glycyrrhetinic acid   -   -   -   -   1件:
63 
 54   Gma161   Gma161   -   -   -   1件:
63 
 55   Hetrombopag olamine   -   -   -   -   2件:
60,
63 
 56   High dose dexamethasone pulses   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
63 
 57   Huaiqihuang granule   -   -   -   -   1件:
63 
 58   Human immunoglobulin   -   -   -   -   1件:
63 
 59   Human immunoglobulin g   Immune globulin human   -   -   -   3件:
14,
50,
63 
 60   Human normal immunoglobulin   Immune globulin human   -   -   -   8件:
11,
13,
14,
43,
45,
50,
63,
65 
 61   Human normal immunoglobulin (iv)   Immune globulin human   -   -   -   4件:
11,
14,
63,
65 
 62   Human normal immunoglobulin for intravenous use   Immune globulin human   -   -   -   2件:
63,
65 
 63   Human normal immunoglobulin for intrvenous use   Immune globulin human   -   -   -   1件:
63 
 64   Human normal immunoglobulin g (igg > 98% purity)   Immune globulin human   -   -   -   2件:
14,
63 
 65   I10e   -   -   -   -   3件:
14,
63,
65 
 66   Ig vena   -   -   -   -   2件:
50,
63 
 67   Ig vena 100 ml vial   -   -   -   -   1件:
63 
 68   Ig vena 50 g/l solution for infusion 100 ml vial + infusion set   -   -   -   -   2件:
63,
65 
 69   Igg next generation   -   -   -   -   2件:
63,
65 
 70   Igiv3i grifols 10%   -   -   -   -   1件:
63 
 71   Ignextgen 10%   -   -   -   -   1件:
63 
 72   Immune globulin intravenous   Immune globulin human   -   -   -   3件:
14,
63,
65 
 73   Immune globulin intravenous (human), 10% triple virally reduced solution   Immune globulin human   -   -   -   1件:
63 
 74   Immunglobulin   -   -   -   -   1件:
63 
 75   Immunoglobulin g   -   -   -   -   7件:
11,
13,
14,
49,
50,
63,
65 
 76   Inactivated trivalent influenza vaccine   -   -   -   -   1件:
63 
 77   Interleukin 2   Human interleukin-2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 78   Intravenous immunoglobulin   Immune globulin human   -   -   -   16件:
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 79   Ivig   Immune globulin human   -   -   -   12件:
11,
13,
14,
17,
18,
50,
51,
63,
65,
85,
164,
296 
 80   Ivig-l   Immune globulin human   -   -   -   1件:
63 
 81   Lansoprazole   Lansoprazole   D00355   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   6件:
63,
71,
98,
166,
222,
299 
 82   Lansoprazole, clarithromycin, amoxycillin   Clarithromycin   D00276   -   -   1件:
63 
 83   Liv-gamma sn inj.   -   -   -   -   1件:
63 
 84   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 85   Medical standard of care for itp   -   -   -   -   1件:
63 
 86   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 87   Metronidazole   Metronidazole   D00409, D05016, D05017   -   -   8件:
46,
51,
63,
94,
95,
96,
97,
291 
 88   Nanogam   -   -   -   -   1件:
63 
 89   Newgam   -   -   -   -   3件:
14,
63,
65 
 90   Nplate   Romiplostim   D08990   1件: MPL   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
63 
 91   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 92   Octagam 10%   -   -   -   -   3件:
50,
63,
65 
 93   Octagam® 10%   -   -   -   -   1件:
63 
 94   Open label (avatrombopag tablets)   Avatrombopag   D10306   -   -   1件:
63 
 95   Palmitate   Palmitic acid   D05341   -   -   1件:
63 
 96   Pf-06755347   -   -   -   -   1件:
63 
 97   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 98   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 99   Privigen®   Immune globulin human   -   -   -   2件:
14,
63 
 100   Proteína recombinante estimulante de la megacariopoyesis   -   -   -   -   1件:
63 
 101   Prtx-100 (staphylococcal protein a)   Bevifimod   -   -   -   1件:
63 
 102   R788   -   -   -   -   2件:
46,
63 
 103   Recombinant human thrombopoietin (rhtpo)   Thrombopoietin   -   -   -   1件:
63 
 104   Revolade   Eltrombopag   D03978   -   -   2件:
60,
63 
 105   Revolade, promacta   Eltrombopag, Eltrombopag   D03978   -   -   1件:
63 
 106   Rhtpo   -   -   -   -   2件:
60,
63 
 107   Rhtpo in combination with rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
63 
 108   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 109   Rituximab [mabthera/rituxan]   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   2件:
46,
63 
 110   Romiplostim   Romiplostim   D08990   1件: MPL   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
60,
63 
 111   Romiplostin   -   -   -   -   1件:
63 
 112   Sb-497115   -   -   -   -   1件:
63 
 113   Sb-497115-gr 12.5mg   -   -   -   -   1件:
63 
 114   Sb-497115-gr 25mg   -   -   -   -   1件:
63 
 115   Sb-497115-gr 50 mg   -   -   -   -   1件:
63 
 116   Sb497115   -   -   -   -   2件:
60,
63 
 117   Sirolimus   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 118   Sm101   -   -   -   -   3件:
49,
63,
66 
 119   Staphylococcal protein a   Bevifimod   -   -   -   1件:
63 
 120   Steroids   -   -   -   -   7件:
46,
50,
51,
63,
66,
96,
97 
 121   Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication)   Clarithromycin   D00276   -   -   1件:
63 
 122   Thrombopoietin   Thrombopoietin   -   -   -   3件:
47,
60,
63 
 123   Triple therapy   -   -   -   -   1件:
63 
 124   Tysabri   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   3件:
13,
25,
63 
 125   Ucb7665   -   -   -   -   2件:
11,
63 
 126   Vonoprazan   Vonoprazan   -   -   -   2件:
63,
98 
 127   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 

先頭へ